Fitzgerald Thomas A
Chief Financial Officer
Award
Calculated transaction value
$0
185,000 shares @ $0
Traded
Sep 9, 2026
Filed
Sep 11, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Transcode Therapeutics, Inc.
RNAZ
Transactions reported in official disclosures
5 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Fitzgerald Thomas A Chief Financial Officer | Sep 11, 2026 2-day lag | Award Sep 9, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Defj, Llc 10% owner | Aug 5, 2026 2-day lag | Conversion Aug 3, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Defj, Llc 10% owner | Aug 5, 2026 2-day lag | Conversion Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Defj, Llc 10% owner | Aug 5, 2026 2-day lag | Conversion Aug 3, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Defj, Llc 10% owner | Aug 5, 2026 2-day lag | Conversion Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Defj, Llc
10% owner
Conversion
Reported value range
Not reported
2,020,582 shares
Traded
Aug 3, 2026
Filed
Aug 5, 2026
Defj, Llc
10% owner
Conversion
Calculated transaction value
$0
1181.39 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 5, 2026
Defj, Llc
10% owner
Conversion
Reported value range
Not reported
11,813,859 shares
Traded
Aug 3, 2026
Filed
Aug 5, 2026
Defj, Llc
10% owner
Conversion
Calculated transaction value
$0
202.06 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 5, 2026